Skip to main content

Should Defeating Aging Be a Civilizational Priority?

Aging kills 100,000 people every day — more than cancer and war combined. Google's Calico has invested billions in life-extension research. Should we treat aging as a disease — or accept it as part of a meaningful life? Two debaters, opposing sides — you score who makes the stronger case.

Wednesday, September 2, 2026 · 7:00 PM EDT

00d 00h 00m

What's at stake

If aging can be treated, every system built around a natural lifespan needs redesigning from scratch. If it can't, the resources spent are a costly distraction.

The Matchup

The Positions

PRO: Aging is the enemy; we should defeat it

Aging kills 100,000 people a day — it is the leading cause of suffering on earth. Treating it as inevitable is a moral failure.

  • Aging causes most of the 150,000 deaths daily — cancer, heart disease, neurodegeneration, immune decline — treating it as a disease rather than inevitability is the most impactful medical priority imaginable.
  • Longevity research has already produced interventions that extend healthspan — the period of healthy life, not just lifespan — and dismissing it as pursuit of immortality is a straw man.
  • A meaningful delay in aging onset could save tens of trillions in healthcare costs and unlock decades of productive contribution from currently healthy older people.

Debater: To be announced

CON: Immortality projects are billionaire hubris

The drive to defeat death is a vanity project of the ultra-wealthy that deepens inequality, distorts research priorities, and misunderstands what makes a life meaningful.

  • Longevity research overwhelmingly benefits the wealthy; in a world where billions lack basic healthcare, redirecting billions toward life extension for those already living comfortably is a profound misallocation.
  • Extended lifespans exacerbate demographic crises already straining pensions, housing, and political power — elderly populations concentrated at the top of wealth distributions would become even more dominant.
  • Finitude gives life urgency and meaning; philosophical traditions from Stoicism to Buddhism treat mortality as a feature; the drive to escape death may be the defining pathology of the tech-billionaire class.

Debater: To be announced

Join the debate

Make Your Case

Record a 60-second video on either side — or make it in writing. The strongest cases get featured before the live debate.

PRO: Aging is the enemy; we should defeat it
CON: Immortality projects are billionaire hubris
Or make your case in writing

Longevity research has already produced interventions that extend healthspan — the period of healthy life, not just total lifespan — in model organisms. Rapamycin, senolytics, and caloric restriction mimetics show measurable effects. Dismissing the field as pursuit of immortality is a straw man of serious biology.

A meaningful delay in aging onset could save tens of trillions in healthcare costs and unlock decades of productive contribution from currently healthy older people. The fiscal and human case for funding this research is stronger than for most conditions that receive far more attention and funding.

Finitude gives life urgency and meaning. Philosophical traditions from Stoicism to Buddhism treat mortality as a feature, not a bug — the awareness of death motivates connection, creativity, and priorities. The drive to escape death may reflect pathology rather than wisdom, and the resources devoted to it might better serve the living.

Longevity research overwhelmingly benefits the wealthy. In a world where billions lack basic healthcare, redirecting billions toward life extension for those already living comfortably is a profound misallocation. The global disease burden from malaria, tuberculosis, and maternal mortality is not declining fast enough to justify diverting resources toward extending the lifespans of the already-healthy.

How It Works

The Format

Standard SuperDebate: two people, cross-examination, moderated from start to finish

4 min

Opening Argument

PRO · opening case

4 min

Cross-Examination

CON questions PRO

4 min

Opening Argument

CON · opening case

4 min

Cross-Examination

PRO questions CON

3 min

Rebuttal

PRO

3 min

Rebuttal

CON

3 min

Closing Statement

PRO · final case

3 min

Closing Statement

CON · final case

Audience Vote

You pick the winner

~28 minutes of debate · audience vote follows closing statements

Don't Miss It

Stay in the Loop

The debate drops when the two sides are confirmed. Get the email the moment it goes live.

Premieres

Wednesday, September 2, 2026 · 7:00 PM EDT

Be the first to watch

One email when it posts. No spam.

Get Involved

Open debate runs on the people who show up. Tell us how you want to be part of it.

I want to…

No spam. We'll only reach out about what you picked.